Positive Long-Term Results Announced on Roflumilast Cream 0.15% for Atopic Dermatitis
This new data had both a consistent long-term safety and tolerability profile with the previous short-term results for the skin disease, and there were no new safety signals recorded.
Source: hcplive.com